Two medical professionals shake hands in a bright, modern clinic with a third person observing in the background.

Join us in creating
high-performance diagnostics

Partnerships

At Medix Biotechnologies, we are at the forefront of molecular innovation. Our primary focus lies in the AI-optimized design, development, manufacturing, and distribution of custom-tailored pathogen detection kits. 

Medix Biotechnologies’ partnership ecosystem engages research experts and industry stakeholders from the United States, Central America, Africa, Southeast Asia, and Europe. These collaborations allow us to drive faster and more precise diagnostic capabilities and build a healthier future for individuals and communities around the globe. 

CLIA Laboratory Partnership 

We partner with Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in the U.S. to improve testing processes and quality, to ensure reimbursements, and to create new products for higher efficiencies and profitability. 

 

Distribution Partnership 

Select companies can become authorized distributors of Medix’s detection kits with attractive discounts and commissions structure. These partners handle distribution, marketing, and sales of Medix kits to laboratories and point-of-care facilities. 

 

Research Collaboration 

We invite laboratories and companies to collaborate with Medix on research projects relating to diagnostics. This partnership involves sharing expertise, resources, and data to advance the understanding of detection methods, develop new technologies, or evaluate the performance of existing products. 

 

Co-Development 

We welcome laboratories and companies to collaborate with us in developing new detection technologies or assays. This partnership involves combining Medix expertise in product development and commercialization with laboratories’ clinical and research expertise. Both parties contribute to the design, validation, and optimization of a project’s detection solutions.